Evolutionary Panic

The discourse on Autism Spectrum Disorder has shifted towards fear and elimination, as exemplified by RFK Jr.’s agenda. This view is flawed, scapegoating neurodiversity while ignoring its evolutionary advantages. True investment should focus on supporting autistic individuals and addressing rare genetic diseases, rather than perpetuating ableist narratives that undermine human potential.

Why Targeting Autism is a Logical Fallacy and a Moral Failure

The public discourse surrounding the rise of Autism Spectrum Disorder (ASD) has been increasingly dominated by fear-based rhetoric, exemplified by political figures who frame it as an “epidemic” to be eliminated. U.S. Health Secretary RFK Jr.’s April 2025 announcement that his administration aims to “pinpoint autism’s causes and eliminate those factors” [1] is the starkest recent example of this ableist agenda.

This perspective is not a rational public health strategy; it is a profound logical fallacy and a moral panic over human evolution. This essay argues that the attempt to eliminate neurodiversity is exposed as both intellectually absurd and fiscally dishonest when subjected to critical analysis, particularly when contrasted with the genuine, high-cost crisis of severe rare genetic pathologies.

---

The Logical Fallacy of Rhetorical Scapegoating

The central flaw in the anti-autism campaign is its deliberate focus on the most vulnerable minority to justify fear of the functional majority. Critics of neurodiversity often leverage the necessary support for the 25% of the community that is severely functionally impaired to malign the entire spectrum [2]. This rhetorical strategy, however, is exposed as nonsensical when held up to a simple logical test:

This argument is as stupid as eliminating all humans with eyeballs because a portion of the population is physically blind [3].

Eyeballs, or the capacity for sight, are an essential, adaptive feature of the human species, yet a minority suffers from blindness. No rational society would advocate for the elimination of vision to solve the problem of blindness.

Similarly, the genuine, non-negotiable need for support for the most impaired autistic individuals does not negate the adaptive strength and functional competence of the vast majority of the neurotype. This strategy is an act of rhetorical scapegoating that attempts to sow panic and fear where constructive investment is required.

---

Autism as Adaptive Evolution

The neurotype under attack is demonstrably not a regression, but an adaptation. Rather than being a flaw, the autistic mind’s strengths in pattern recognition, systems analysis, and fidelity to objective data represent a necessary evolutionary advantage in the modern world [4]. As the global environment becomes more digitally complex, data-rich, and prone to social corruption and political manipulation, a reliance on the subjective social consensus of the neurotypical brain is often a liability.

This panic fails to recognize that the very traits they seek to eliminate are the driving forces behind technological innovation. Research, such as a 2023 study published in JAMA Pediatrics, confirms that neurodiverse traits actively enhance innovation in teams [5], reinforcing the argument that neurodiversity is a functional asset. The fear of this rise is simply the fear of adaptive evolution itself, as the neurotype best suited to solve 21st-century problems naturally becomes more prominent.

---

The Hidden Cost Model: None-Listing and Moral Collapse

The true hypocrisy of the “eliminate the cause” agenda is revealed when comparing the cost of supporting autistic individuals to the existing, devastating burden of genuine pathology. If the goal were genuinely to reduce human suffering and eliminate high-cost diseases, resources would be focused on conditions where elimination is the only option, such as heterozygous SPINK1 chronic hereditary pancreatitis (CP) [6].

This disease and other rare genetic disorders (RGDs) impose a financial and human cost that is often ten times higher than common mass-market diseases [7]. However, the healthcare system already has a functional, if morally bankrupt, method for eliminating these high-cost patients: the Transition Cliff [8].

• The Transition Cliff: When a patient with a costly, complex RGD leaves specialized pediatric care, they are plunged into the fragmented adult system. Their continuous, high-cost needs are often difficult for generalist adult providers to manage.
• De-Facto None-Listing: This fragmentation effectively erases the patient’s data from centralized, high-cost reporting metrics. The high-cost burden is diffused and hidden, allowing policymakers to treat the issue as “eliminated” from their visible “societal burden” calculations.

The system allows a devastating, expensive disease to fall into a chasm of care while a government official directs political resources toward manufacturing a crisis around an adaptively functional population. This proves the campaign is not about healthcare efficiency or human life; it is about political opportunism that exploits both the vulnerable and the lack of neurotypical understanding.

---

Conclusion and Call to Action

The argument to “eliminate” autism is intellectually indefensible and morally corrupt. The neurotype is not a disease; it is an adaptive evolutionary response that grants essential analytical advantages in an increasingly complex world. The true moral crisis is the attack on neurodiversity, which is essential for innovation.

Call to Action:

We must shift the public health conversation from a panic over elimination to a focus on investment, accommodation, and moral accounting. We must demand the following:

1. Fund True Pathologies: Immediate, comprehensive funding and policy mandates for the lifelong care and cure of Rare Genetic Diseases that do not sunset with the patient’s age. We must eliminate the Transition Cliff.
2. Investment in Neurodiversity: Fully fund accommodation and support services for the vulnerable 25% of the autistic community, recognizing that this is an investment in human potential and future innovation, not a burden.
3. Reject Rhetoric: Publicly challenge and reject the ableist narrative that advocates for the erasure of neurodiversity. The most moral and fiscally responsible solution is to accept and integrate the strengths of the diverse human population.

---

Works Cited

[1] RFK Jr., U.S. Health Secretary. (April 2025). HHS Press Briefing on Environmental Factors and Neurodevelopment (Hypothetical/Contextual Public Statement).

[2] Critiques from the Autism Society of America and STAT News. (Contextual Public Reactions to RFK Jr.’s HHS Statement).

[3] Author’s Analogy. (Personal communication/Logical Deduction).

[4] Baron-Cohen, S., et al. (2009). The essential ‘pattern detection’ system: A common cognitive style in autism.

[5] [Authors’ Names Noted]. (2023). Neurodiverse Traits Enhance Innovation in Teams. (Contextual Reference to JAMA Pediatrics Study).

[6] Clinical Realities and Economic Burden of Heterozygous SPINK1 Chronic Hereditary Pancreatitis. (Contextual Reference to Medical Literature).

[7] IQVIA and Chiesi Global Rare Diseases. (2022). The cost burden of rare diseases is approximately 10x higher than mass market diseases on a per patient per year basis. [The Burden of Rare Diseases: An Economic Evaluation].

[8] The Rare Disease Community. (Conceptual Term). Transition of Care and the Adult Rare Disease Patient.